CREB1 and gastric adenocarcinoma: IGF2-AS has been reported to play anti-cancer efficacy via ceRNA mechanism in some other cancers, such as in gastric cancer via miR-195/CREB1 axis [7] and in gastric adenocarcinoma via miR-503/SHOX2 axis [22].